News

Spravato, which is derived from ketamine, is not a new drug—it first ... Despite the approval, Johnson & Johnson’s stock (JNJ) dipped Wednesday after the company’s quarterly earnings release.
A mid-stage trial of oral ketamine tablets has shown promising results in treatment-resistant depression (TRD), setting up a phase 3 programme and a possible challenge to Johnson & Johnson’s ...
An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...
The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...
A Home Office spokesperson said the rise in ketamine use identified in wastewater analysis was “deeply concerning” and the policing minister, Diana Johnson, has asked the Advisory Council on ...
That's why today, ketamine is increasingly being used to treat a variety of illnesses, including depression, anxiety, post-traumatic stress disorder (PTSD) and chronic pain.